Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes With PrognosisKaren Dybkær, Hans Erik Johnsen, Martin Bøgsted et al.|Journal of Clinical Oncology|2015Cited by 125
Long Noncoding RNA Expression during Human B-Cell DevelopmentAndreas Petri, Sakari Kauppinen, Karen Dybkær et al.|PLoS ONE|2015Cited by 104
miR-155 as a Biomarker in B-Cell MalignanciesHanne Due, Karen Dybkær, Pernille Svendsen et al.|BioMed Research International|2016Cited by 83
The myeloma stem cell concept, revisited: from phenomenology to operational termsHans Erik Johnsen, Karen Dybkær, Martin Bøgsted et al.|Haematologica|2016Cited by 76
High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphomaSara Correia Marques, Karen Dybkær, Benyamin Ranjbar et al.|Experimental Hematology|2016Cited by 68